Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015, Article ID 424783, 6 pages
http://dx.doi.org/10.1155/2015/424783
Research Article

The Measurement of Intraocular Biomarkers in Various Stages of Proliferative Diabetic Retinopathy Using Multiplex xMAP Technology

1Department of Ophthalmology, University Hospital Pilsen, Alej Svobody 80, 304 60 Plzen, Czech Republic
2Department of Nuclear Medicine, Laboratory of Immunoanalysis, University Hospital Pilsen, Dr. E. Benese 13, 305 99 Plzen, Czech Republic
3Central Radioisotopic Laboratory, Faculty of Medicine in Pilsen, Charles University in Prague, Dr. E. Benese 13, 305 99 Plzen, Czech Republic

Received 19 December 2014; Accepted 27 February 2015

Academic Editor: Ricardo Giordano

Copyright © 2015 Stepan Rusnak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Adeghate, P. Schattner, and E. Dunn, “An update on the etiology and epidemiology of diabetes mellitus,” Annals of the New York Academy of Sciences, vol. 1084, pp. 1–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Klein and B. Klein, The Beaver Dam Eye Study, 1987–2010, http://www.bdeyestudy.org/.
  3. B. E. K. Klein, “Overview of epidemiologic studies of diabetic retinopathy,” Ophthalmic Epidemiology, vol. 14, no. 4, pp. 179–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Simó, E. Carrasco, M. García-Ramírez, and C. Hernández, “Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy,” Current Diabetes Reviews, vol. 2, no. 1, pp. 71–98, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. F. Gariano and T. W. Gardner, “Retinal angiogenesis in development and disease,” Nature, vol. 438, no. 7070, pp. 960–966, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. F. Spaide, “Peripheral areas of nonperfusion in treated central retinal vein occlusion as imaged by wide-field fluorescein angiography,” Retina, vol. 31, no. 5, pp. 829–837, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Kellar and M. A. Iannone, “Multiplexed microsphere-based flow cytometric assays,” Experimental Hematology, vol. 30, no. 11, pp. 1227–1237, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Maier, M. Weger, E.-M. Haller-Schober et al., “Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients,” Molecular Vision, vol. 14, pp. 637–643, 2008. View at Google Scholar · View at Scopus
  9. P. Murugeswari, D. Shukla, A. Rajendran, R. Kim, P. Namperumalsamy, and V. Muthukkaruppan, “Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease,” Retina, vol. 28, no. 6, pp. 817–824, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Yoshimura, K.-H. Sonoda, M. Sugahara et al., “Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases,” PLoS ONE, vol. 4, no. 12, Article ID e8158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Freyberger, M. Bröcker, H. Yakut et al., “Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy,” Experimental and Clinical Endocrinology & Diabetes, vol. 108, no. 2, pp. 106–109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Funatsu, H. Yamashita, T. Mimura, H. Noma, S. Nakamura, and S. Hori, “Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines,” Eye, vol. 21, no. 3, pp. 377–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Curnow, F. Falciani, O. M. Durrani et al., “Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis,” Investigative Ophthalmology and Visual Science, vol. 46, no. 11, pp. 4251–4259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Funding, T. K. Hansen, J. Gjedsted, and N. Ehlers, “Simultaneous quantification of 17 immune mediators in aqueous humour from patients with corneal rejection,” Acta Ophthalmologica Scandinavica, vol. 84, no. 6, pp. 759–765, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Rusnak, J. Vrzalova, L. Hecová, M. Kozova, O. Topolcan, and R. Ricarova, “Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber,” Biomarkers in Medicine, vol. 7, no. 5, pp. 759–767, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. J. Sohn, D. H. Han, I. T. Kim et al., “Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema,” American Journal of Ophthalmology, vol. 152, no. 4, pp. 686–694, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Saint-Geniez, A. S. R. Maharaj, T. E. Walshe et al., “Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors,” PLoS ONE, vol. 3, no. 11, Article ID e3554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. A. Campochiaro, D. F. Choy, D. V. Do et al., “Monitoring ocular drug therapy by analysis of aqueous samples,” Ophthalmology, vol. 116, no. 11, pp. 2158–2164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. T. U. Krohne, N. Eter, F. G. Holz, and C. H. Meyer, “Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans,” The American Journal of Ophthalmology, vol. 146, no. 4, pp. 508–512, 2008. View at Publisher · View at Google Scholar · View at Scopus